KEARNEY, Neb.--(BUSINESS WIRE)--SCORR Marketing, a global full-service marketing and communications firm focused on the health sciences industry, in association with Applied Clinical Trials, has released the results of a comprehensive survey on the use of mHealth wearable technology in clinical trials.
mHealth is characterized by the use of mobile technology, such as smartphones, tablets, apps, patient monitoring devices, wearables and other wireless devices. The report details how companies are currently using mHealth wearable technologies and also looks at companies’ concerns about data security, costs, patient compliance and environmental factors. It also provides insight into the ways wearable technology will be utilized in the future.
“We are excited for the opportunity to educate the health sciences industry on this emerging technology and for the chance to partner with Applied Clinical Trials,” said Joanna Disley, director of market intelligence and European operations. We are constantly looking for ways to deliver insightful information to the clinical research industry.”
"Mobile health technologies continues to be a hot topic in our industry and we appreciate the opportunity to work with SCORR to keep our audience up to date on its evolving adoption," said Lisa Henderson, editor of Applied Clinical Trials, which is part of UBM Americas.
For additional insight regarding mHealth wearables in the clinical trials, download the full report for free at scorrmarketing.com and view the article in Applied Clinical Trials at appliedclinicaltrialsonline.com.
About SCORR Marketing
SCORR Marketing, a full-service marketing and communications firm, is dedicated to achieving results for its global clients by combining strategy and creativity. SCORR has locations across North America and Europe. For more information, visit www.scorrmarketing.com.